Fragile X syndrome and connective tissue dysregulation.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
02 2019
Historique:
received: 16 10 2018
accepted: 03 11 2018
pubmed: 11 11 2018
medline: 31 3 2020
entrez: 11 11 2018
Statut: ppublish

Résumé

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disabilities and autism spectrum disorders, and it is an X-linked disorder in which there is a deficiency of the fragile X mental retardation 1 protein. This protein is crucial in regulating translation of mRNAs related to dendritic maturation and cognitive development. The phenotype of FXS is characterized by neurobehavioral alterations, social deficits, communication difficulties, and findings which suggest an alteration of connective tissue, especially in the ligaments and muscles, cardiovascular system and genitourinary system. Connective tissue connects and supports all other tissues of the body and is composed of cells and extracellular matrix (ECM). Several proteins have been involved in the connective tissue abnormalities associated with the FXS, such as matrix metalloproteinase 9, which plays an important role in the homeostasis of the ECM, being a potential therapeutic target for certain tetracycline antibiotics that have shown beneficial effects in FXS. Here, we review connective tissue problems described in FXS.

Identifiants

pubmed: 30414172
doi: 10.1111/cge.13469
doi:

Substances chimiques

Extracellular Matrix Proteins 0
FMR1 protein, human 0
Fragile X Mental Retardation Protein 139135-51-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-267

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Julián A Ramírez-Cheyne (JA)

Departamento de Morfología Universidad del Valle, Cali, Colombia.

Gustavo A Duque (GA)

Departamento de Morfología Universidad del Valle, Cali, Colombia.

Sebastián Ayala-Zapata (S)

Departamento de Morfología Universidad del Valle, Cali, Colombia.

Wilmar Saldarriaga-Gil (W)

Departamento de Morfología Universidad del Valle, Cali, Colombia.

Paul Hagerman (P)

UC Davis MIND Institute, University of California, Davis, California.

Randi Hagerman (R)

UC Davis MIND Institute, University of California, Davis, California.

César Payán-Gómez (C)

Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH